The transdermal recombinant feline leukemia vaccine: Top 10 questions.

In this article the author discusses the top 10 questions related to the transdermal recombinant feline leukemia vaccine. The first question asks about the difference between the recombinant canarypox-vectored vaccine and the other feline leukemia virus vaccines (FeLV) available in the market. In the United States, there are currently four licensed FeLV vaccines on the market. Two of these vaccines are killed, whole virus vaccines; one is a subunit vaccine that contains selected viral proteins of FeLV. The newest FeLV vaccine is a recombinant canarypox-vectored vaccine.